Euroapi S.A. (LON:0EAP)

Market Cap	181.50M -28.9%
Revenue (ttm)	756.73M -9.1%
Net Income	-106.55M
EPS	-1.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	924
Average Volume	6,157
Open	2.149
Previous Close	2.178
Day's Range	2.137 - 2.186
52-Week Range	2.054 - 3.530
Beta	0.59
RSI	47.17
Earnings Date	Mar 3, 2026

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Employees: 3,187
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0EAP

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial numbers in EUR